Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization.
The source filing: Astrana Health’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 6:01 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213157
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses | ||
| Cost of services, excluding depreciation and amortization | 859,356 | 549,061 |
| General and administrative expenses | 61,737 | 43,897 |
| Depreciation and amortization | 15,479 | 6,849 |
| Total expenses | 936,572 | 599,807 |
| Income from operations | 28,528 | 20,583 |
| Other (expense) income | ||
| Income (loss) from equity method investments | 1,720 | (867) |
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Astrana Health's D&A?
- Astrana Health (ASTH) reported D&A of $15.48M in Q1 2026.
- How has Astrana Health's D&A changed year-over-year?
- Astrana Health's D&A increased by 126.0% year-over-year, from $6.85M to $15.48M.
- What is the long-term trend for Astrana Health's D&A?
- Over 4 years (2021 to 2025), Astrana Health's D&A has grown at a 27.1% compound annual growth rate (CAGR), from $17.52M to $45.75M.
- What does D&A mean?
- This metric represents the portion of depreciation and amortization expenses directly attributable to the production of goods or the delivery of services. It reflects the systematic allocation of the cost of tangible and intangible assets used in core operational activities over their useful lives. Monitoring this figure helps investors assess the capital intensity of the company's primary business model.
Ask your AI about Astrana Health's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude